Keynote SpeakersView All Speakers
Malcolm Wilson The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester
Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours
Professor Jayant Vaidya University College London
Targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer
Dr Abeer Shaaban Queen Elizabeth Hospital Birmingham & University of Birmingham
Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations
Lucinda Billingham University of Birmingham - Cancer Research Clinical Trials Unit
National Lung Matrix Trial: testing multiple novel targeted treatments
Mr Hamish Clouston The Christie NHS Foundation Trust
Surgical Management of Advanced Colonic and Rectal Malignancies.
Dr Natalie Cook University of Manchester/Christie NHS Foundation Trust
Molecular testing and novel therapies in prostate cancer
Dr Khurum Khan University College London Hospitals
Translational research in GI Oncology- how to make progress?
Dr Catherine Coyle Christie Hospital NHS Foundation Trust
Prostate Cancer- the non surgical oncologists view
Professor Noel Clarke The Christie and Salford Royal Hospitals, Manchester UK
Improving Prostate Cancer Outcomes Through Cancer Trials
Prof Ingunn Holen Department of Oncology and Metabolism, University of Sheffield, UK
Tumour cell dormancy and breast cancer relapse
Stand No: 738
Stand No: 768
Stand No: 740
Stand No: 798
Stand No: 708
Stand No: 792
Stand No: 724
Stand No: 800
News And BlogsView More
Breast cancer. It’s the most common and aggressive cancer in the...
The prevention of disease is an integral focus of the European...
The Rutherford Cancer Centre North East and Northumbria Healthcare has announced...
‘’MIT biologists have now found that by combining two existing classes...
The Oncology industry is right at the forefront of pioneering new...